{"date":"2026-03-27","count":29,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6814-2026-03-27-2115-drgvb6","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"21:15:57","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-03-27 21:15，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-03-27-2052-bwopfv","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"20:52:40","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-03-27 20:52，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-03-27-2051-11b1948","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"20:51:21","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-03-27 20:51，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2026-03-27-2040-3t287q","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2026-03-27","time":"20:40:07","subject":"本公司電子拋棄式支氣管鏡ECB100通過歐盟醫療器材法規EU MDR審查","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2026-03-27 20:40，「本公司電子拋棄式支氣管鏡ECB100通過歐盟醫療器材法規EU MDR審查」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6814-2026-03-27-2004-1b89la1","company_id":"6814","company":"路迦生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"20:04:48","subject":"公告本公司董事會通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：路迦生醫（6814），2026-03-27 20:04，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-03-27-1922-p1h1y8","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-03-27","time":"19:22:47","subject":"本公司註銷限制員工權利新股減資變更登記完成","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-03-27 19:22，「本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-03-27-1915-16gqwqw","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-03-27","time":"19:15:59","subject":"公告本公司膠原蛋白植入劑產品取得泰國醫療器材許可證。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-03-27 19:15，「公告本公司膠原蛋白植入劑產品取得泰國醫療器材許可證。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7724-2026-03-27-1852-15npde0","company_id":"7724","company":"諾亞克","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"18:52:40","subject":"依櫃買中心證櫃審字第11500006721號來文指示補充本公司對前總經理暨董事沈家平及董事暨前副總經理鄭詩靜進行訴訟(含告訴)後續進度","clause":"第2款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：諾亞克（7724），2026-03-27 18:52，「依櫃買中心證櫃審字第11500006721號來文指示補充本公司對前總經理暨董事沈家平及董事暨前副總經理鄭詩靜進行訴訟(含」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2026-03-27-1818-fy1trf","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-03-27","time":"18:18:30","subject":"本公司向馬來西亞國家藥品管理局（NPRA）提交恩穩健腸病毒71型疫苗新藥審查(NDA)","clause":"第10款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-03-27 18:18，「本公司向馬來西亞國家藥品管理局（NPRA）提交恩穩健腸病毒71型疫苗新藥審查(NDA)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-27-1757-1n5sse0","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"17:57:09","subject":"本公司代子公司思捷優達股份有限公司公告其與Shake It Up 澳洲巴金森氏症基金會 (Shake It UpAustralia Foundation) 簽署合作備忘錄","clause":"第8款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-27 17:57，「本公司代子公司思捷優達股份有限公司公告其與Shake It Up 澳洲巴金森氏症基金會 (Shake It UpAust」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-27-1756-2y8l0x","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"17:56:23","subject":"本公司代子公司思捷優達股份有限公司公告其與挪威卑爾根健康 HF 豪克蘭大學醫院簽署合作備忘錄","clause":"第8款","fact_date":"2026-03-02","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-27 17:56，「本公司代子公司思捷優達股份有限公司公告其與挪威卑爾根健康 HF 豪克蘭大學醫院簽署合作備忘錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-03-27-1752-1i4duoa","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-03-27","time":"17:52:21","subject":"更正本公司114年度合併財報iXBRL申報資訊(更正待註銷股本股數及每股淨值)","clause":"第53款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-03-27 17:52，「更正本公司114年度合併財報iXBRL申報資訊(更正待註銷股本股數及每股淨值)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2026-03-27-1751-kcpyse","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"17:51:01","subject":"本公司代子公司思捷優達股份有限公司公告其與澳洲暨紐西蘭動作障礙協會臨床試驗聯盟(MDSANZ CTN)簽署合作備忘錄","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2026-03-27 17:51，「本公司代子公司思捷優達股份有限公司公告其與澳洲暨紐西蘭動作障礙協會臨床試驗聯盟(MDSANZ CTN)簽署合作備忘錄」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-03-27-1739-1aivjuz","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"17:39:06","subject":"代子公司開啟基因股份有限公司公告新任董事及監察人暨董事變動達三分之一","clause":"第6款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-03-27 17:39，「代子公司開啟基因股份有限公司公告新任董事及監察人暨董事變動達三分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-03-27-1729-11b1948","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"17:29:57","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-03-27 17:29，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7754-2026-03-27-1702-5sggiz","company_id":"7754","company":"安基生技","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"17:02:35","subject":"本公司受邀參加第一金證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安基生技（7754），2026-03-27 17:02，「本公司受邀參加第一金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2026-03-27-1650-92x690","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"16:50:57","subject":"董事會決議股利分派","clause":"第31款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2026-03-27 16:50，「董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4121-2026-03-27-1650-rp7e9n","company_id":"4121","company":"優盛","market":"上櫃","industry":"生技醫療","date":"2026-03-27","time":"16:50:52","subject":"公告董事會決議擬延長處份部份子公司佑全藥品(股)公司股權案之授權期間。","clause":"第20款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：優盛（4121），2026-03-27 16:50，「公告董事會決議擬延長處份部份子公司佑全藥品(股)公司股權案之授權期間。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-27-1642-qxbnm8","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"16:42:49","subject":"公告本公司召開重大訊息說明記者會及新聞稿內容","clause":"第44款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-27 16:42，「公告本公司召開重大訊息說明記者會及新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2026-03-27-1640-1b89la1","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"16:40:34","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2026-03-27 16:40，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6744-2026-03-27-1636-1howjn","company_id":"6744","company":"豐技生技","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"16:36:03","subject":"公告本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：豐技生技（6744），2026-03-27 16:36，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4106-2026-03-27-1618-geamda","company_id":"4106","company":"雃博","market":"上市","industry":"生技醫療","date":"2026-03-27","time":"16:18:25","subject":"公告本公司召開115年第一次法人說明會","clause":"第12款","fact_date":"2026-04-08","cite_as":"公開資訊觀測站重大訊息：雃博（4106），2026-03-27 16:18，「公告本公司召開115年第一次法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-27-1433-1howjn","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"14:33:09","subject":"公告本公司董事會決議召開115年股東常會","clause":"第32款","fact_date":"2026-03-27","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-27 14:33，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-27-1415-r2mzf0","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"14:15:47","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第二,三,四款規定公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-27 14:15，「本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第二,三,四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-27-1411-isqttc","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"14:11:34","subject":"公告本公司董事會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-27 14:11，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-27-1404-lebi8d","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"14:04:51","subject":"公告本公司召開重大訊息說明記者會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-27 14:04，「公告本公司召開重大訊息說明記者會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-03-27-1401-141snzi","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-03-27","time":"14:01:18","subject":"公告由於美國國家衛生研究院轄下國家癌症研究所贊助計畫到期，本公司由美國兒童腦瘤聯盟(PBTC)主導執行之髓母細胞瘤第1/2期人體臨床試驗終止。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-03-27 14:01，「公告由於美國國家衛生研究院轄下國家癌症研究所贊助計畫到期，本公司由美國兒童腦瘤聯盟(PBTC)主導執行之髓母細胞瘤第1/」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2026-03-27-1342-1w655rm","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"13:42:52","subject":"本公司董事會決議通過子公司GB Holdings Limited及代重要子公司居禮股份有限公司公告換股投資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：普生（4117），2026-03-27 13:42，「本公司董事會決議通過子公司GB Holdings Limited及代重要子公司居禮股份有限公司公告換股投資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6539-2026-03-27-1127-1dd9qx8","company_id":"6539","company":"麗彤","market":"興櫃","industry":"生技醫療","date":"2026-03-27","time":"11:27:48","subject":"公告本公司董事會決議召開115年股東常會事宜","clause":"第32款","fact_date":"2026-03-26","cite_as":"公開資訊觀測站重大訊息：麗彤（6539），2026-03-27 11:27，「公告本公司董事會決議召開115年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}